CYBB and chronic granulomatous disease: Since the majority of CGD patients present mutations in the gp91phox/Cybb subunit (about 70%) or in the p47phox/Ncf1 subunit (about 20%) of NOX2, several studies have focused on understanding the immune response in corresponding animal models [6]–[9].